{"product_id":"global-precision-medicine-market-size-study-forecast-by-technology-big-data-analytics-bioinformatics-gene-sequencing-drug-discovery-companion-diagnostics-and-other-technologies-by-application-oncology-cns-immunology-respiratory-and-other-a","title":"Global Precision Medicine  Market Size study \u0026 Forecast, by Technology ( Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Other Technologies) by Application ( Oncology, CNS, Immunology, Respiratory and Other A","description":"\u003cp\u003eGlobal Precision Medicine  Market Size study \u0026amp; Forecast, by Technology ( Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Other Technologies) by Application ( Oncology, CNS, Immunology, Respiratory and Other Applications), and Regional Analysis, 2022-2029\u003cbr\u003e\nGlobal Precision Medicine  Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision medicine is an emerging science that focuses treatment decisions on a patient's genetic profile, way of life, and environment. The success of precision medicine in treating cancer has led to an increase in its popularity. It enables medical professionals and researchers to forecast more precise treatment and prevention measures for every specific disease. Precision medicine, which focuses on the mutations that turn healthy bodily cells into cancerous ones, is often referred to as personalized medicine or tailored medicine. In comparison to conventional medications, the use of precision medicine in targeted cancer treatment offers fewer adverse effects and promotes faster recovery. The Precision Medicine market is expanding because of factors such as increasing incidence of central nerves system disorders and advancement in cancer biology.\u003cbr\u003e\nSeveral gene therapies, diagnostics, and medications have been created in this field as a result of the rise in the prevalence of serious illnesses including cancer and uncommon diseases. According to estimates from the International Agency for Research on Cancer (IARC), globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018. It is estimated to increase the worldwide burden of cancer to 27.5 million new cases by 2040. Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth launched a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative organize and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the growth. In addition, higher technological advancements of precision medicine and growing investments associated with precision medicine is creating a lucrative growth to the market.  However, high cost for precision medicine development halt market growth.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Precision Medicine  Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Technologies and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nAstarte Medical\u003cbr\u003e\nAstraZeneca PLC\u003cbr\u003e\nF Hoffmann-La Roche Ltd.\u003cbr\u003e\nLaboratory Corporation of America Holdings\u003cbr\u003e\nMedtronic PLC\u003cbr\u003e\nMyriad Genetics Inc.\u003cbr\u003e\nNovartis AG\u003cbr\u003e\nPfizer Inc.\u003cbr\u003e\nQiagen NV\u003cbr\u003e\nQuest Diagnostics\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\nIn November 2022, The University of Pécs (UP) and BGI Genomics decided to open a collaborative lab in Hungary. The collaborative lab will begin formal operations in order to strengthen BGI Genomics' and the UP's avant-garde precision medicine advancements in the Central and Eastern European region and to speed the development of genomic sequencing and clinical diagnostic services.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Precision Medicine  Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Technology, Application, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Technology:\u003cbr\u003e\nBig Data Analytics\u003cbr\u003e\nBioinformatics\u003cbr\u003e\nGene Sequencing\u003cbr\u003e\nDrug Discovery\u003cbr\u003e\nCompanion Diagnostics\u003cbr\u003e\n Other Technologies\u003c\/p\u003e\n\n\u003cp\u003eBy Application:\u003cbr\u003e\nOncology\u003cbr\u003e\n CNS\u003cbr\u003e\n Immunology\u003cbr\u003e\n Respiratory\u003cbr\u003e\n Other Applications\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRoLA\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eAstarte Medical\u003cbr\u003e\nAstraZeneca PLC\u003cbr\u003e\nF Hoffmann-La Roche Ltd.\u003cbr\u003e\nLaboratory Corporation of America Holdings\u003cbr\u003e\nMedtronic PLC\u003cbr\u003e\nMyriad Genetics Inc.\u003cbr\u003e\nNovartis AG\u003cbr\u003e\nPfizer Inc.\u003cbr\u003e\nQiagen NV\u003cbr\u003e\nQuest Diagnostics\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 200 Pages \/ MCW16229851","offer_id":47647010193714,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-precision-medicine-market-size-study-forecast-by-technology-big-data-analytics-bioinformatics-gene-sequencing-drug-discovery-companion-diagnostics-and-other-technologies-by-application-oncology-cns-immunology-respiratory-and-other-a","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}